-
1
-
-
59649100565
-
Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors
-
Anandan SK, Do ZN, Webb HK, Patel DV, Gless RD, (2009). Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett 19: 1066-1070.
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 1066-1070
-
-
Anandan, S.K.1
Do, Z.N.2
Webb, H.K.3
Patel, D.V.4
Gless, R.D.5
-
2
-
-
57149086269
-
Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model
-
Batchu SN, Law E, Brocks DR, Falck JR, Seubert JM, (2009). Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J Mol Cell Cardiol 46: 67-74.
-
(2009)
J Mol Cell Cardiol
, vol.46
, pp. 67-74
-
-
Batchu, S.N.1
Law, E.2
Brocks, D.R.3
Falck, J.R.4
Seubert, J.M.5
-
3
-
-
33745274726
-
Mitochondria: Dynamic organelles in disease, aging, and development
-
Chan DC, (2006). Mitochondria: dynamic organelles in disease, aging, and development. Cell 125: 1241-1252.
-
(2006)
Cell
, vol.125
, pp. 1241-1252
-
-
Chan, D.C.1
-
4
-
-
75749084460
-
Inhibition of soluble epoxide hydrolase by trans-4-[4-(3-adamantan-1-yl- ureido)-cyclohexyloxy]-benzoic acid (t-AUCB) is protective against ischemia reperfusion injury
-
Chaudhary KR, Abukhashim M, Hwang SH, Hammock BD, Seubert JM, (2009a). Inhibition of soluble epoxide hydrolase by trans-4-[4-(3-adamantan-1-yl-ureido)- cyclohexyloxy]-benzoic acid (t-AUCB) is protective against ischemia reperfusion injury. J Cardiovasc Pharmacol 55: 67-73.
-
(2009)
J Cardiovasc Pharmacol
, vol.55
, pp. 67-73
-
-
Chaudhary, K.R.1
Abukhashim, M.2
Hwang, S.H.3
Hammock, B.D.4
Seubert, J.M.5
-
5
-
-
67650221165
-
Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function
-
Chaudhary KR, Batchu SN, Das D, Suresh MR, Falck JR, Graves JP, et al. (2009b). Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function. Cardiovasc Res 83: 362-370.
-
(2009)
Cardiovasc Res
, vol.83
, pp. 362-370
-
-
Chaudhary, K.R.1
Batchu, S.N.2
Das, D.3
Suresh, M.R.4
Falck, J.R.5
Graves, J.P.6
-
6
-
-
34548755151
-
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
-
Chiamvimonvat N, Ho CM, Tsai HJ, Hammock BD, (2007). The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol 50: 225-237.
-
(2007)
J Cardiovasc Pharmacol
, vol.50
, pp. 225-237
-
-
Chiamvimonvat, N.1
Ho, C.M.2
Tsai, H.J.3
Hammock, B.D.4
-
7
-
-
39149128273
-
Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia
-
Dhanasekaran A, Gruenloh SK, Buonaccorsi JN, Zhang R, Gross GJ, Falck JR, et al. (2008). Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol 294: H724-H735.
-
(2008)
Am J Physiol Heart Circ Physiol
, vol.294
-
-
Dhanasekaran, A.1
Gruenloh, S.K.2
Buonaccorsi, J.N.3
Zhang, R.4
Gross, G.J.5
Falck, J.R.6
-
8
-
-
0037232845
-
Comparison of vasodilatory properties of 14,15-EET analogs: Structural requirements for dilation
-
Falck JR, Krishna UM, Reddy YK, Kumar PS, Reddy KM, Hittner SB, et al. (2003). Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation. Am J Physiol Heart Circ Physiol 284: H337-H349.
-
(2003)
Am J Physiol Heart Circ Physiol
, vol.284
-
-
Falck, J.R.1
Krishna, U.M.2
Reddy, Y.K.3
Kumar, P.S.4
Reddy, K.M.5
Hittner, S.B.6
-
9
-
-
69049118113
-
14,15-epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: Influence upon vascular relaxation and soluble epoxide hydrolase inhibition
-
Falck JR, Kodela R, Manne R, Atcha KR, Puli N, Dubasi N, et al. (2009). 14,15-epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition. J Med Chem 52: 5069-5075.
-
(2009)
J Med Chem
, vol.52
, pp. 5069-5075
-
-
Falck, J.R.1
Kodela, R.2
Manne, R.3
Atcha, K.R.4
Puli, N.5
Dubasi, N.6
-
10
-
-
0030811403
-
Cytochrome P450 metabolites of arachidonic acid: Rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells
-
Fang X, Kaduce TL, Weintraub NL, Spector AA, (1997). Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells. Prostaglandins Leukot Essent Fatty Acids 57: 367-371.
-
(1997)
Prostaglandins Leukot Essent Fatty Acids
, vol.57
, pp. 367-371
-
-
Fang, X.1
Kaduce, T.L.2
Weintraub, N.L.3
Spector, A.A.4
-
11
-
-
0036889533
-
Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide
-
Fang X, Weintraub NL, Oltman CL, Stoll LL, Kaduce TL, Harmon S, et al. (2002). Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. Am J Physiol Heart Circ Physiol 283: H2306-H2314.
-
(2002)
Am J Physiol Heart Circ Physiol
, vol.283
-
-
Fang, X.1
Weintraub, N.L.2
Oltman, C.L.3
Stoll, L.L.4
Kaduce, T.L.5
Harmon, S.6
-
12
-
-
9344238842
-
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels
-
Fang X, Weintraub NL, McCaw RB, Hu S, Harmon SD, Rice JB, et al. (2004). Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. Am J Physiol Heart Circ Physiol 287: H2412-H2420.
-
(2004)
Am J Physiol Heart Circ Physiol
, vol.287
-
-
Fang, X.1
Weintraub, N.L.2
McCaw, R.B.3
Hu, S.4
Harmon, S.D.5
Rice, J.B.6
-
13
-
-
0018968692
-
The stability of 13,14-dihydro-15 keto-PGE2
-
Fitzpatrick FA, Aguirre R, Pike JE, Lincoln FH, (1980). The stability of 13,14-dihydro-15 keto-PGE2. Prostaglandins 19: 917-931.
-
(1980)
Prostaglandins
, vol.19
, pp. 917-931
-
-
Fitzpatrick, F.A.1
Aguirre, R.2
Pike, J.E.3
Lincoln, F.H.4
-
14
-
-
1542512379
-
14,15-EET analogs: Characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries
-
Gauthier KM, Falck JR, Reddy LM, Campbell WB, (2004). 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Pharmacol Res 49: 515-524.
-
(2004)
Pharmacol Res
, vol.49
, pp. 515-524
-
-
Gauthier, K.M.1
Falck, J.R.2
Reddy, L.M.3
Campbell, W.B.4
-
15
-
-
33847419892
-
Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts
-
Gross GJ, Hsu A, Falck JR, Nithipatikom K, (2007). Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. J Mol Cell Cardiol 42: 687-691.
-
(2007)
J Mol Cell Cardiol
, vol.42
, pp. 687-691
-
-
Gross, G.J.1
Hsu, A.2
Falck, J.R.3
Nithipatikom, K.4
-
16
-
-
33747331141
-
Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase
-
Jones PD, Tsai HJ, Do ZN, Morisseau C, Hammock BD, (2006). Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett 16: 5212-5216.
-
(2006)
Bioorg Med Chem Lett
, vol.16
, pp. 5212-5216
-
-
Jones, P.D.1
Tsai, H.J.2
Do, Z.N.3
Morisseau, C.4
Hammock, B.D.5
-
17
-
-
85047692700
-
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore
-
Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, et al. (2004). Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113: 1535-1549.
-
(2004)
J Clin Invest
, vol.113
, pp. 1535-1549
-
-
Juhaszova, M.1
Zorov, D.B.2
Kim, S.H.3
Pepe, S.4
Fu, Q.5
Fishbein, K.W.6
-
18
-
-
67650717705
-
Epoxyeicosatrienoic acids: Formation, metabolism and potential role in tissue physiology and pathophysiology
-
Kaspera R, Totah RA, (2009). Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology. Expert Opin Drug Metab Toxicol 5: 757-771.
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 757-771
-
-
Kaspera, R.1
Totah, R.A.2
-
19
-
-
67349123094
-
Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells
-
Katragadda D, Batchu SN, Cho WJ, Chaudhary KR, Falck JR, Seubert JM, (2009). Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells. J Mol Cell Cardiol 46: 867-875.
-
(2009)
J Mol Cell Cardiol
, vol.46
, pp. 867-875
-
-
Katragadda, D.1
Batchu, S.N.2
Cho, W.J.3
Chaudhary, K.R.4
Falck, J.R.5
Seubert, J.M.6
-
20
-
-
1842555060
-
Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility
-
Kim IH, Morisseau C, Watanabe T, Hammock BD, (2004). Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility. J Med Chem 47: 2110-2122.
-
(2004)
J Med Chem
, vol.47
, pp. 2110-2122
-
-
Kim, I.H.1
Morisseau, C.2
Watanabe, T.3
Hammock, B.D.4
-
21
-
-
0033567249
-
Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes
-
(Pt 1).
-
Lee HC, Lu T, Weintraub NL, VanRollins M, Spector AA, Shibata EF, (1999). Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes. J Physiol 519 (Pt 1): 153-168.
-
(1999)
J Physiol
, vol.519
, pp. 153-168
-
-
Lee, H.C.1
Lu, T.2
Weintraub, N.L.3
Vanrollins, M.4
Spector, A.A.5
Shibata, E.F.6
-
22
-
-
13844316739
-
Epoxide hydrolases: Mechanisms, inhibitor designs, and biological roles
-
Morisseau C, Hammock BD, (2005). Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 45: 311-333.
-
(2005)
Annu Rev Pharmacol Toxicol
, vol.45
, pp. 311-333
-
-
Morisseau, C.1
Hammock, B.D.2
-
23
-
-
57049115027
-
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo
-
Motoki A, Merkel MJ, Packwood WH, Cao Z, Liu L, Iliff J, et al. (2008). Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. Am J Physiol Heart Circ Physiol 295: H2128-H2134.
-
(2008)
Am J Physiol Heart Circ Physiol
, vol.295
-
-
Motoki, A.1
Merkel, M.J.2
Packwood, W.H.3
Cao, Z.4
Liu, L.5
Iliff, J.6
-
24
-
-
0042330513
-
Preconditioning: Is the Akt-ion in the PI3K pathway?
-
Murphy E, Tong H, Steenbergen C, (2003). Preconditioning: is the Akt-ion in the PI3K pathway? J Mol Cell Cardiol 35: 1021-1025.
-
(2003)
J Mol Cell Cardiol
, vol.35
, pp. 1021-1025
-
-
Murphy, E.1
Tong, H.2
Steenbergen, C.3
-
25
-
-
62349105876
-
Cardiac regulation by phosphoinositide 3-kinases and PTEN
-
Oudit GY, Penninger JM, (2009). Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 82: 250-260.
-
(2009)
Cardiovasc Res
, vol.82
, pp. 250-260
-
-
Oudit, G.Y.1
Penninger, J.M.2
-
26
-
-
79251513275
-
Soluble epoxide hydrolase inhibitors and heart failure
-
[Epub ahead of print].
-
Qiu H, Li N, Liu JY, Harris TR, Hammock BD, Chiamvimonvat N, (2010). Soluble epoxide hydrolase inhibitors and heart failure. Cardiovasc Ther. [Epub ahead of print].
-
(2010)
Cardiovasc Ther
-
-
Qiu, H.1
Li, N.2
Liu, J.Y.3
Harris, T.R.4
Hammock, B.D.5
Chiamvimonvat, N.6
-
27
-
-
63849131965
-
Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats
-
Revermann M, Barbosa-Sicard E, Dony E, Schermuly RT, Morisseau C, Geisslinger G, et al. (2009). Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats. J Hypertens 27: 322-331.
-
(2009)
J Hypertens
, vol.27
, pp. 322-331
-
-
Revermann, M.1
Barbosa-Sicard, E.2
Dony, E.3
Schermuly, R.T.4
Morisseau, C.5
Geisslinger, G.6
-
28
-
-
4444236138
-
Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway
-
Seubert J, Yang B, Bradbury JA, Graves J, Degraff LM, Gabel S, et al. (2004). Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ Res 95: 506-514.
-
(2004)
Circ Res
, vol.95
, pp. 506-514
-
-
Seubert, J.1
Yang, B.2
Bradbury, J.A.3
Graves, J.4
Degraff, L.M.5
Gabel, S.6
-
29
-
-
33747422507
-
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function
-
Seubert JM, Sinal CJ, Graves J, DeGraff LM, Bradbury JA, Lee CR, et al. (2006). Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 99: 442-450.
-
(2006)
Circ Res
, vol.99
, pp. 442-450
-
-
Seubert, J.M.1
Sinal, C.J.2
Graves, J.3
Degraff, L.M.4
Bradbury, J.A.5
Lee, C.R.6
-
30
-
-
0022410248
-
Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs)
-
Spearman ME, Prough RA, Estabrook RW, Falck JR, Manna S, Leibman KC, et al. (1985). Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs). Arch Biochem Biophys 242: 225-230.
-
(1985)
Arch Biochem Biophys
, vol.242
, pp. 225-230
-
-
Spearman, M.E.1
Prough, R.A.2
Estabrook, R.W.3
Falck, J.R.4
Manna, S.5
Leibman, K.C.6
-
31
-
-
66349109660
-
Arachidonic acid cytochrome P450 epoxygenase pathway
-
(Suppl.).
-
Spector AA, (2009). Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res 50 (Suppl.): S52-S56.
-
(2009)
J Lipid Res
, vol.50
-
-
Spector, A.A.1
-
32
-
-
0242720683
-
Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function
-
Spector AA, Fang X, Snyder GD, Weintraub NL, (2004). Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43: 55-90.
-
(2004)
Prog Lipid Res
, vol.43
, pp. 55-90
-
-
Spector, A.A.1
Fang, X.2
Snyder, G.D.3
Weintraub, N.L.4
-
33
-
-
0032578999
-
Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B
-
Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, et al. (1998). Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279: 710-714.
-
(1998)
Science
, vol.279
, pp. 710-714
-
-
Stephens, L.1
Anderson, K.2
Stokoe, D.3
Erdjument-Bromage, H.4
Painter, G.F.5
Holmes, A.B.6
-
34
-
-
48249116482
-
PIP2 is a necessary cofactor for ion channel function: How and why?
-
Suh BC, Hille B, (2008). PIP2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys 37: 175-195.
-
(2008)
Annu Rev Biophys
, vol.37
, pp. 175-195
-
-
Suh, B.C.1
Hille, B.2
-
35
-
-
0037040856
-
Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase - Dependent pathway is cardioprotective
-
Tong H, Imahashi K, Steenbergen C, Murphy E, (2002). Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res 90: 377-379.
-
(2002)
Circ Res
, vol.90
, pp. 377-379
-
-
Tong, H.1
Imahashi, K.2
Steenbergen, C.3
Murphy, E.4
-
36
-
-
63149137137
-
Discovery of potent non-urea inhibitors of soluble epoxide hydrolase
-
Xie Y, Liu Y, Gong G, Smith DH, Yan F, Rinderspacher A, et al. (2009). Discovery of potent non-urea inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett 19: 2354-2359.
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 2354-2359
-
-
Xie, Y.1
Liu, Y.2
Gong, G.3
Smith, D.H.4
Yan, F.5
Rinderspacher, A.6
-
37
-
-
34248570494
-
Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: Use for studies of metabolism and ligand binding
-
Yang W, Holmes BB, Gopal VR, Kishore RV, Sangras B, Yi XY, et al. (2007). Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand binding. J Pharmacol Exp Ther 321: 1023-1031.
-
(2007)
J Pharmacol Exp Ther
, vol.321
, pp. 1023-1031
-
-
Yang, W.1
Holmes, B.B.2
Gopal, V.R.3
Kishore, R.V.4
Sangras, B.5
Yi, X.Y.6
-
38
-
-
67650073361
-
Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity
-
Zhang Y, El-Sikhry H, Chaudhary KR, Batchu SN, Shayeganpour A, Jukar TO, et al. (2009). Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 297: H37-H46.
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.297
-
-
Zhang, Y.1
El-Sikhry, H.2
Chaudhary, K.R.3
Batchu, S.N.4
Shayeganpour, A.5
Jukar, T.O.6
|